Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Department of Oncology and Hemato-Oncology University of Milan

1 abstract

Abstract
eVOLVE-HNSCC: A global phase 3 study of volrustomig as sequential therapy for unresected locally advanced head and neck squamous cell carcinoma (LA-HNSCC) following definitive concurrent chemoradiotherapy (cCRT).
Org: Head and Neck Medical Oncology Unit, Department of Oncology and Hemato-Oncology University of Milan,